Skip to main content

Toronto's Bridgepoint Hospital is coping with an H1N1 outbreak after 11 patients and five health-care workers in the hospital's Neuromuscular Support Unit contracted the virulent flu strain, the hospital said in a release issued Thursday.

Two of the 16 people experiencing the symptoms have been referred to acute-care hospitals for further care, and other patients and health-care workers in the ward are being treated with antivirals and the H1N1 vaccine.

"Bridgepoint Health is working with Toronto Public Health and our Infectious Disease Specialists to manage the outbreak and contain its spread," Bridgepoint President and CEO Marian Walsh said in the statement. "From the onset of the outbreak, we responded as though the virus was H1N1, which lab results now confirm. We were not going to take any chances."

Story continues below advertisement

The release emphasized the flu outbreaks are common in hospitals at this time of year, but cautioned visitors and staff not to come to hospital if they're experiencing flu-like symptoms.

On Wednesday, Barbara Yaffe, Toronto's associate medical officer of health, confirmed an outbreak of H1N1 at Mount Sinai hospital. There were three cases of influenza among patients and staff in the intensive-care unit.



Report an error
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter